Biofrontera Inc.
BFRI
Rank in Stocks
#31669
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Share Price
$0.7977
Market Cap
$11.85M
Change (1 day)
-2.91%
Change (1 year)
-72.96%
Country
US
Trade Biofrontera Inc. (BFRI)
Category
Healthcare
Revenue for Biofrontera Inc. (BFRI)
Revenue in Oct 2026 TTM: 0
According to Biofrontera Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biofrontera Inc. from 2026 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $2.54B | - |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $830.81M | - |
US
|
